NCT04454138View on ClinicalTrials.gov

Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

April 20, 2020

Study Completion Date

April 20, 2020

Conditions
Glaucoma
Interventions
DEVICE

XEN-45 gelatin microstent

Placement either in the subconjunctival space or supratenon's area

Trial Locations (1)

L6H 0J8

Prism Eye Institute, Oakville

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Prism Eye Institute

OTHER